Existencias: The impact of quadrivalent human papillomavirus (HPV; Types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years

The impact of quadrivalent human papillomavirus (HPV; Types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years

Background. Human papillomavirus (HPV)-6/11/16/18 vaccine reduces the risk of HPV-6/11/16/18-related cervical intraepithelial neoplasia (CIN) 1-3 or adenocarcinoma in situ (AIS). Here, its impact on CIN1-3/AIS associated with nonvaccine oncogenic HPV types was evaluated. Methods. We enrolled 17,622...

Descripción completa

Detalles Bibliográficos
Autores Principales:	Brown, Darron R, Kjaer, Susanne K, Sigurdsson, Kristján, Iversen, Ole-Erik, Hernandez-Avila, Mauricio, Wheeler, Cosette M, Perez, Gonzalo, Koutsky, Laura A, Tay, Eng Hseon, Garcia, Patricía, Ault, Kevin A, Garland, Suzanne M., Leodolter, Sepp, Olsson, Sven-Eric, Tang, Grace W K, Ferris, Daron G., Paavonen, Jorma, Steben, Marc, Bosch, F Xavier, Dillner, Joakim, Joura, Elmar A., Kurman, Robert J, Majewski, Slawomir, Muñoz, Nubia, Myers, Evan R, Villa, Luisa L, Taddeo, Frank J, Roberts, Christine, Tadesse, Amha, Bryan, Janine, Lupinacci, Lisa C, Giacoletti, Katherine E D, Sings, Heather L, James, Margaret, Hesley, Teresa M, Barr, Eliav
Formato:	Artículo (Article)
Lenguaje:	Inglés (English)
Publicado:	2009
Materias:	Placebo Wart virus vaccine Adolescent Adult Article Cancer prevention Clinical trial Condyloma acuminatum Controlled clinical trial Controlled study Disease duration Double blind procedure Drug efficacy Female Human Human papillomavirus type 11 Human papillomavirus type 16 Human papillomavirus type 18 Human papillomavirus type 31 Human papillomavirus type 45 Human papillomavirus type 6 Infection prevention Major clinical study Papanicolaou test Phase 3 clinical trial Priority journal Randomized controlled trial Uterine cervix biopsy Uterine cervix cancer Uterine cervix carcinoma in situ Uterine cervix cytology Vaccination Alphapapillomavirus Classification Genetics Immunology Uterine cervix tumor Virology Virus infection Humans Papillomavirus infections Papillomavirus vaccines Uterine cervical neoplasms Young adult
Acceso en línea:	https://repository.urosario.edu.co/handle/10336/22373 https://doi.org/10.1086/597307

Internet

https://repository.urosario.edu.co/handle/10336/22373
https://doi.org/10.1086/597307

The impact of quadrivalent human papillomavirus (HPV; Types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years

Internet

Ejemplares similares